11.1 Midwives Exemptions under Human Medicines Regulations 2012 & PGDs

Midwives Exemptions under Human Medicines Regulations 2012 & PGDs

Medicines management in United Kingdom midwifery practice operates under a strict, multi-layered statutory framework designed to safeguard maternal and neonatal health while ensuring timely access to essential pharmacotherapy. Midwives are autonomous practitioners who routinely make complex pharmacological decisions during the antenatal, intrapartum, and postnatal periods. To practice safely and effectively within the UK healthcare system, every registered midwife must possess an in-depth understanding of the Human Medicines Regulations 2012, the scope and limitations of Schedule 17 Midwives Exemptions, the operational architecture of Patient Group Directions (PGDs), and the precise legal requirements of Patient Specific Directions (PSDs).

---

The Statutory Framework: Human Medicines Regulations 2012

The overarching primary legislation governing the manufacture, licensing, distribution, prescription, and administration of medicinal products across the United Kingdom is the Human Medicines Regulations 2012 (SI 2012/1916), which consolidated and updated previous provisions from the Medicines Act 1968 and associated statutory instruments. Under UK law, all medicinal products are categorized into three distinct legal classifications:

1. General Sales List (GSL) Medicines: Medicines that can be sold or supplied in general retail outlets (such as supermarkets or newsagents) without the supervision of a registered pharmacist, provided the premises can be secured against public access and the packaging remains intact.
2. Pharmacy (P) Medicines: Medicinal products that can only be sold or supplied from a registered retail pharmacy under the personal supervision of a registered pharmacist, without requiring a doctor's prescription.
3. Prescription-Only Medicines (POM): Potentially potent or high-risk medicinal products that, under general legal provisions (Regulation 214), can only be sold, supplied, or administered in accordance with a written prescription issued by an authorized appropriate practitioner (such as a registered medical practitioner, dentist, or an annotated independent prescriber).

Under standard legal circumstances, administering or supplying a Prescription-Only Medicine without a valid prescription from an authorized prescriber constitutes a strict liability criminal offence. However, recognizing the unique, autonomous nature of normal childbirth and the requirement for immediate obstetric interventions, UK law embeds specific statutory mechanisms that permit registered midwives to supply and administer POMs without a conventional prescriber's order.

---

Midwives Exemptions under Schedule 17

The midwives exemptions are set out in regulation 235 and Schedule 17 of the Human Medicines Regulations 2012. They allow a registered midwife (RM), acting in the course of professional practice, to sell or supply, and to administer by injection, specified medicines to women and babies in her care without a prescription, a Patient Specific Direction or a Patient Group Direction. The exemptions authorise supply and administration only; they do not confer prescribing rights.

Scope and Legal Conditions of the Exemption

The statutory exemption is subject to clear legal boundaries:

• Professional Course of Practice: The exemption applies only while the midwife is caring for a woman in pregnancy, labour or the postnatal period, or for her baby.
• Registered Status: The practitioner must hold current registration in the midwives' part of the NMC register.
• Student Midwives: Schedule 17 Part 3 allows student midwives to administer the listed parenteral medicines under the direct supervision of a registered midwife, except diamorphine, morphine and pethidine. Students may help check and prepare controlled drugs, but may not administer them under the exemptions.
• Fixed List: The exemption is limited to the substances listed in Schedule 17. Midwives cannot extend the list, however urgent the situation; anything else needs a prescription, PSD or PGD.

The Schedule 17 Lists

Sale or supply (Part 1): a registered midwife may sell or supply all medicines that are not prescription-only (GSL and P medicines) within her practice, plus the prescription-only medicines diclofenac, hydrocortisone acetate, miconazole, nystatin and phytomenadione. She may also supply parenteral diamorphine, morphine and pethidine in the course of professional practice (with controlled drug requirements, such as a midwife's supply order, applying).

Parenteral administration (Part 3): a registered midwife may administer the following by injection, and a student midwife may do so under direct supervision (except the three opioids):

---

Patient Group Directions (PGDs)

A Patient Group Direction (PGD) is a specific legal framework defined in the Human Medicines Regulations 2012 as an authorized, written instruction for the sale, supply, and/or administration of a specified named licensed medicine (or medicines) to a defined cohort of patients who present with a particular clinical condition, without the need for an individualized doctor's prescription.

Clinical and Governance Architecture of a PGD

PGDs are not informal guidelines or local preferences; they are legally binding documents subject to rigorous multidisciplinary scrutiny and governance standards established by the National Institute for Health and Care Excellence (NICE MPG2) and the Medicines and Healthcare products Regulatory Agency (MHRA).

┌─────────────────────────────────────────────────────────────────┐
│               PGD MULTIDISCIPLINARY DEVELOPMENT                 │
│    Consultant Obstetrician (Doctor) + Lead Clinical Pharmacist   │
└────────────────────────────────┬────────────────────────────────┘
                                 │
                                 ▼
┌─────────────────────────────────────────────────────────────────┐
│                 FORMAL CLINICAL GOVERNANCE                      │
│     Trust Drugs & Therapeutics Committee (Authorising Body)     │
└────────────────────────────────┬────────────────────────────────┘
                                 │
                                 ▼
┌─────────────────────────────────────────────────────────────────┐
│                 NAMED INDIVIDUAL AUTHORISATION                  │
│   Midwife undergoes competency training, signs individual PGD   │
└────────────────────────────────┬────────────────────────────────┘
                                 │
                                 ▼
┌─────────────────────────────────────────────────────────────────┐
│                     CLINICAL EXECUTION                          │
│      Midwife assesses woman against strict Inclusion/Exclusion  │
│              Supplies or administers specified medicine         │
└─────────────────────────────────────────────────────────────────┘

Mandatory Legal Components of a PGD

Every PGD must contain explicit, non-negotiable criteria:

1. Multidisciplinary Sign-off: The PGD must be collaboratively developed and signed by a senior registered doctor (e.g., Clinical Director of Obstetrics) and a senior registered pharmacist, and subsequently ratified by an authorized corporate body (e.g., NHS Trust Medical Director or Governance Committee).
2. Named Authorized Professionals: Only qualified, registered healthcare professionals specifically named and authorized by their healthcare organization can operate under the PGD. The midwife must have completed mandatory training, verified their clinical competence, and signed the formal organizational PGD register.
3. Strict Inclusion and Exclusion Criteria: The PGD must explicitly define which women qualify for the medicine and identify absolute contraindications that prohibit its administration under the direction.
4. Pharmaceutical Details: Exact generic name, approved brand names, dosage form, strength, maximum dose, dosing intervals, and route of administration.
5. Adverse Effects & Emergency Protocols: Comprehensive warnings, management of recognized adverse drug reactions, and mandatory reporting protocols via the MHRA Yellow Card Scheme.
6. Documentation: Clear requirements for recording the woman's details, date, time, batch number, expiry date, dose administered, and the signature of the administering midwife in the maternal health record.

Critical Restrictions on PGD Use

• No Delegation: The supply and administration of medicines under a PGD cannot be delegated. A registered midwife cannot assess a woman under a PGD and then instruct a maternity support worker (MSW) or unregistered colleague to administer the drug. Student midwives cannot act as the named authorised professional under a PGD and should not administer medicines under a PGD, even under supervision; the named registered midwife must supply and administer the medicine personally.
• Unlicensed Medicines Prohibition: As a general statutory rule, PGDs cannot be used to supply or administer unlicensed medicinal products (with very narrow exceptions such as COVID-19 pandemic vaccines or licensed medicines used off-label where supported by robust national guidance). If an unlicensed medicine or complex off-label regimen is required, a Patient Specific Direction (PSD) is mandatory.

---

Patient Specific Directions (PSDs)

A Patient Specific Direction (PSD) is the traditional legal mechanism for medication administration. It is a written, signed instruction (or validated electronic prescribing system order) issued by an authorized independent prescriber (such as a registered medical practitioner or an annotated midwife independent prescriber) for a specifically named patient.

Characteristics of a PSD in Maternity Settings

• Individualized Clinical Assessment: The prescriber directly examines or reviews the specific patient and determines the exact clinical necessity of the drug.
• Broadest Pharmacological Scope: Unlike PGDs and exemptions, a PSD can encompass any licensed, off-label, or unlicensed medicine, provided the prescriber accepts clinical and legal responsibility for the prescription.
• Common Maternity Examples: Prescriptions for prophylactic low-molecular-weight heparin (enoxaparin or dalteparin), therapeutic intravenous labetalol for acute severe pre-eclampsia, targeted intrapartum intravenous antibiotics (such as benzylpenicillin or clindamycin) for maternal pyrexia or chorioamnionitis, and sliding-scale insulin infusions for diabetic ketoacidosis.
• Delegation Under a PSD: A registered midwife can safely administer a medicine prescribed under a PSD, and in certain defined circumstances, administration can be supervised or delegated to competent registered staff or student midwives adhering to local trust medication administration policies.

---

Comparative Synthesis: Exemptions vs. PGDs vs. PSDs

To pass the NMC CBT examination and practice with legal clarity, midwives must master the operational and legal distinctions among these three pathways:

---

Prescribing Qualifications: Independent vs. Supplementary Prescribing

Midwives exemptions must not be conflated with independent prescribing. While Schedule 17 exemptions grant registered midwives the legal authority to supply and administer specific medicines, they do not grant the authority to generate open prescriptions for outpatient dispensing or prescribe medicines outside the statutory schedule.

The V300 Prescribing Programme

To prescribe medicines independently, a registered midwife must undertake specialized post-registration education:

• Independent Prescriber (IP - V300): Midwives who complete an NMC-approved prescribing qualification (V300) have their registration entry annotated as a Midwife Independent/Supplementary Prescriber.
• Scope of Practice: An annotated midwife independent prescriber can independently assess women, determine differential diagnoses, and prescribe any licensed medicine, off-label medicine, and designated Controlled Drugs (Schedules 2, 3, 4, and 5) that fall within their verified sphere of clinical competence in maternity and reproductive healthcare.
• Supplementary Prescribing: A partnership mechanism between an independent medical prescriber, the supplementary midwife prescriber, and the patient, governed by an agreed patient-specific Clinical Management Plan (CMP). This model is frequently utilised in long-term chronic conditions complicating pregnancy, such as maternal diabetes, hypertension, or epilepsy.